Skip to content
Screener

Staar Surgical STAA Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$94.7MBeat by $19.2M
EPS$0.46Beat by $0.28
Revenue estimate$75.5M
EPS estimate$0.18

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$79.1M
EPS estimate$0.20

Financials

Q3 2025

Income statement

See full
Revenue$94.7M+6.9%
Gross profit$77.9M+13.7%
Operating income$18.5M+225%
Net income$8.9M-11.0%
EPS (diluted)$0.18-10.0%

Balance sheet

See full
Cash & equivalents$176.2M+7.4%
Total debt$39.1M-2.2%
Total equity$353.8M-17.4%
Total assets$456.4M-15.1%

Cash flow

See full
Operating cash flow--100%
CapEx$883.0K-85.8%
Free cash flow-+100%

Valuation & ratios

Valuation

as of 09/26/25
See full
Market cap$1.28B-10.5%
Enterprise value$1.14B-12.5%
P/S5.5×+1.4×

Profitability

See full
Gross margin73.9%-4.9pp
Operating margin-42%-49.5pp
Net margin-41.8%-48.2pp
FCF margin-17.9%—

Returns & leverage

See full
Return on equity-24.6%-30.0pp
Debt / equity0.1×0.0×
Current ratio5.2×-0.8×

Segments

By geography

See full
Other Countries$22.0M+5.4%

FAQ

When did Staar Surgical report Q3 2025 earnings?
Staar Surgical (STAA) reported Q3 2025 earnings on November 5, 2025 after market close.
What were Staar Surgical's Q3 2025 revenue and EPS?
Staar Surgical reported revenue of $94.7M and eps of $0.46 for Q3 2025.
Did Staar Surgical beat estimates in Q3 2025?
Revenue beat the consensus estimate of $75.5M by $19.2M. EPS beat the consensus estimate of $0.18 by $0.28.
How did Staar Surgical's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.9% from $88.6M a year earlier and eps grew 24.3% from $0.37.
Where can I find Staar Surgical's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-266857) and the 10-Q periodic report (0001193125-25-266879) directly on SEC EDGAR. The filing index links above go to sec.gov.